Cacti Asset Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
GS
AA
MAM
DO
QCM
EAM
CGH
CUAMC
Cacti Asset Management's LKFT Position: Q2 2026 in Review
Cacti Asset Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2026, closing a stake of 1,000 shares — an estimated $30K sold.
Cacti Asset Management first reported a position in LKFT in Q3 2020 and held it in 23 quarters. The position peaked at $355K in Q3 2020. 24 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.
- Cacti Asset Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2026 after selling out during the quarter.
- Cacti Asset Management sold 1,000 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $30K.
- Cacti Asset Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2020 and held it in 23 quarters.
- Cacti Asset Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $355K in Q3 2020.
- 24 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.
Based on Cacti Asset Management's 13F filing for Q2 2026, filed 1 Jul 2026.